Scientific publications

New preclinical biomarkers for prion diseases in the cerebrospinal fluid proteome revealed by mass spectrometry

A team of researchers led by the University of Zaragoza has identified five proteins in cerebrospinal fluid (CSF) that could act as early biomarkers for the diagnosis of prion diseases, before the first clinical symptoms appear. The study, carried out in sheep with scrapie - a natural model of these neurodegenerative pathologies - used advanced mass spectrometry and ELISA techniques to analyse the alterations in the CSF proteome.

Read more
en_GBEnglish (UK)